← Back
Data updated: Jun 12, 2026
ANDRX PHARM
Pharma Pharmaceuticals
ANDRX PHARM is a pharmaceutical company with 2 FDA-approved products.
2004
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
ANDRX PHARM's Key Drugs
ANDRX PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
ANDRX PHARM's Recent FDA Approvals
New NDA/BLA approvals for ANDRX PHARM over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
ANDRX PHARM's Therapeutic Areas
Disease areas where ANDRX PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ANDRX PHARM Pipeline Snapshot
Active clinical trials for ANDRX PHARM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2004-04-27
- Latest
- 2018-11-08
- Applications
- 2
FDA Sponsor Names
ANDRX PHARMANDRX LABS LLC